Clinical Trial Update: Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy trial of dexmethylphenidate in children with ADHD has completed, reporting on its safety and efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• FOCALIN (DEXMETHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Novartis | Conditions: ADHD | Phase 3 | Status: COMPLETED